Data Science Innovation: Driving Alzheimer’s Disease Insights

For years, data analytics has been used in healthcare to fuel faster and more accurate diagnoses, inform decision-making, personalize treatment, improve patient care and outcomes, lower costs and more. With recent advances in the use of big data and generative artificial intelligence, more organizations are exploring new ways to apply these modern data science tools to address persistent healthcare challenges.

One of the key challenges in advancing care for the growing population living with Alzheimer’s disease and related dementias is the aggregation of meaningful insights from a wide range of disparate sources of raw data, including electronic health records (EHRs), personal health records, patient portals and health-related smart phone apps, in addition to large amounts of unstructured data, strict data privacy and security regulations and a variety of data formats.

To drive innovation forward in this space, MATTER recently launched the Restoring Brain Health Innovation Challenge with support from the Lundbeck US Charitable Fund to identify and accelerate the development of data science technologies that can generate novel insights from disparate sources to advance care in Alzheimer’s disease and related dementias.

On September 18, join Mary Furlong, leader in the longevity market, Elizabeth Powers, Vice President and General Manager, US Regulatory Science & Study Innovation at IQVIA and Ryan Urbanowicz, Research Scientist, Computational Biomedicine at Cedars-Sinai Medical Center and Co-Lead, Tech ID and Training Core, PennAITech/a2Collective.ai for a conversation exploring this topic.

Agenda

12:00–12:45pm CT | Panel conversation

12:45-1:00pm CT | Overview of the 2023 Restoring Brain Health Innovation Challenge

About the speakers:

Mary Furlong

Leader in Longevity Market

Mary Furlong, Ed.D., President and CEO of Mary Furlong & Associates (MFA), is a leading authority on the longevity marketplace. Successful social and serial entrepreneur, (SeniorNet (1986), ThirdAge Media (1996), and MFA (2002)), Mary has secured over $140 million in venture financing and corporate sponsorships for companies with products and services to serve the needs of the boomer/senior marketplace. Next Avenue named Mary one of its “2016 Influencers in Aging,” she is also a past winner of the Silicon Valley Business Journal’s “Top 100 Women of Influence” award, and the author of Turning Silver into Gold: How to Profit in the New Boomer Marketplace.

Mary produces the industry-leading What’s Next Boomer Business Summit and the Silicon Valley Boomer Venture Summit and Business Plan Competition. She has appeared on NBC, CBS, and NPR and is an advisor to the Ziegler Link•age Longevity Fund, L.P., the Thrive Center, and the Centre for Aging + Brain Health Innovation.

MFA’s private client practice is comprised of many of the leading startups and corporations in the longevity marketplace. She also serves as an adjunct professor, focusing on entrepreneurship and women in leadership at the Leavey School of Business at Santa Clara University, CA.

Elizabeth Powers

Vice President and General Manager, US Regulatory Science & Study Innovation, IQVIA

Elizabeth, vice president and general manager of regulatory science and study innovation in IQVIA’s U.S. regional business unit, has over 20 years of experience in biotech and pharma with a focus in real world evidence. Her responsibilities include driving innovative real-world evidence generation through emerging methodologies such as patient-mediated data, AI/ML and data networks. She has led multiple complex real-world studies supporting regulatory submissions, including external comparator studies for gene therapies and rare diseases. Prior to joining IQVIA in 2013, Elizabeth was a partner at Booz & Co. where she received a Hammer Award for Reinventing Government and Booz Allen Hamilton’s Professional Excellence Award. She has published articles in Harvard Business Review, InVivo and Financial Executive International. She holds a BA in mathematics from St. John’s College, Annapolis and Santa Fe, and an MBA in finance and information strategy from The Wharton School at University of Pennsylvania.

Ryan Urbanowicz

Assistant Professor, Computational Biomedicine, Cedars-Sinai Medical Center

Adjunct Assistant Professor of Informatics, University of Pennsylvania

Co-Lead, Tech ID and Training Core, PennAITech/a2Collective.ai

Dr. Ryan Urbanowicz is an assistant professor of computational biomedicine at the Cedars Sinai Medical Center and adjunct assistant professor of informatics at the University of Pennsylvania. His research focuses on the development of machine learning, artificial intelligence automation and data mining methodologies as well as their application to a variety of biomedical and clinical research domains. His research group has developed a number of open-source software packages including, most recently, STREAMLINE, a simple, transparent, end-to-end automated machine learning pipeline. You can learn more about his research as well as check out his many lectures and educational videos on artificial intelligence and machine learning on his YouTube channel, The URBS-Lab.

About About the Lundbeck US Charitable Fund

The Lundbeck US Charitable Fund is an independently managed nonprofit 501(c)(3) committed to responsibly and appropriately supporting organizations and programs that share our dedication to restoring brain health. The Lundbeck US Charitable Fund is wholly owned by H. Lundbeck A/S, a global pharmaceutical company specialized in brain diseases. For more than 70 years, Lundbeck has been at the forefront of neuroscience research, tirelessly dedicated to restoring brain health so every person can be their best.

About MATTER

At MATTER, we believe collaboration is the best way to improve healthcare. The MATTER collaborative includes more than 800 current and alumni startups from around the world, working together with dozens of hospitals and health systems, universities and industry-leading companies to build the future of healthcare. Together we are accelerating innovation, advancing care and improving lives. For more information, visit matter.health and follow @MATTERhealth.